You are here

  • Home
  • Archive
  • Volume 15, Issue 1
  • Adding atypical antipsychotics to antidepressants increases response in treatment-resistant major depression but increases discontinuation as a result of adverse events

Article info

Article menu
Download PDFPDF
Therapeutics
Systematic review
Adding atypical antipsychotics to antidepressants increases response in treatment-resistant major depression but increases discontinuation as a result of adverse events

Authors

  1. Gabor I Keitner
    Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA; GKeitner{at}Lifespan.org
View Full Text

Citation

Keitner GI
Adding atypical antipsychotics to antidepressants increases response in treatment-resistant major depression but increases discontinuation as a result of adverse events
BMJ Evidence-Based Medicine 2010;15:19-20.

Publication history

  • First published February 22, 2010.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions